The ability of HPSE to activate PI3K/Akt in a non-enzymatic manner, essentially bypassing PTEN signalling as previously discussed, is evidence of its ability to counter tumour-suppressive mechanisms [62]. The gene discussed is PTEN; the disease is neoplasm.